Automatic Cell Imaging System MarketSize and Trends

Automatic Cell Imaging System Market – Dynamics

As the occurrence of cancer is rising at an alarming rate, so is the need for automatic cell imaging system. Automatic cell imaging system offers grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market.

Rising prevalence of cancer is expected to propel the automatic cell imaging system market over the forecast period. According to the World Cancer Research Fund International (WCRFI), in 2012, around 14.1 million cancer cases were estimated worldwide, in which, around 7.4 men and 6.6 million female were diagnosed. As per WCRFI, it is predicted that by 2035, world-wide around 24 million cancer cases will increase. The most common cancers were breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases).

Rising product approvals and product launch by the market players is expected to propel the market growth. For instance, in February 2018, Molecular Devices, LLC, launched ImageXpress Pico Automated Cell Imaging System which automates the manual procedures such as acquisition steps and post processing of images and offers user efficient tool in research work